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ABSTRACT
Objective: The incidence of solid renal masses has increased sharply in recent years due to widespread use of abdominal 
imaging studies. The aim of the present study was to evaluate the incidence of benign lesions in solid renal masses ac-
cording to tumor size.
Materials and Methods: The authors retrospectively reviewed the records of 305 patients with 328 renal solid masses 
treated by surgery. Based on a report by one pathologist, the specimen tumor size and the histology of each lesion were 
tabulated. The frequency of renal cell carcinoma and benign renal lesions was evaluated and a correlation between tumor 
size and pathological features of the masses was observed.
Results: The frequency of malignant lesions in the 328 renal masses was 83.2%. When lesions were stratified into groups 
with diameters ≤ 3 cm or > 3 cm, the incidence of benign histology was 22.9% and 13.3%, respectively (p = 0.026). The 
odds ratios for finding a benign lesion in masses ≤ 3 cm was 1.93 (IC 95%, 1.07 - 3.46) compared to masses > 3 cm.
Conclusion: The incidence of benign lesions is significantly higher in renal masses smaller than 3 cm in diameter, which 
should be taken in account when the treatment of renal solid masses is planned.
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INTRODUCTION
 Renal cell carcinomas (RCCs) represent 
between 3% and 4% of neoplasms found in clinics 
(1) and their incidence has been rising about 3% per 
year since 1975 (2). In the past, 85% of the expansive 
lesions found in kidneys were related to RCC, while 
the remaining lesions were benign local disorders (3). 
In recent years, with the introduction of new imaging 
methods like ultrasound, CAT scan, and magnetic 
resonance, there has been a significant increase in 
the detection of asymptomatic and incidental renal 
tumors, cases that now outnumber tumors identified 
after the onset of symptoms. Currently, up to 71% of 
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the solid renal masses are found incidentally during 
abdominal imaging studies (2,3). In these cases, the 
lesions are usually smaller and are frequently benign 
(4-7).
 The finding of benign disorders in a signifi-
cant number of patients with solid renal masses has 
practical implications that cannot be ignored. The 
adoption of indiscriminate surgical treatment in all 
cases of renal masses will result in unnecessary inter-
ventions and even the undue loss of kidneys in patients 
without malignant disease. To avoid this dilemma, 
many authors advise a pre-op percutaneous biopsy 
in cases of solid renal masses (8,9). Although these 
tests are highly accurate,  biopsy is not sufficiently 
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accurate in all cases and can fail in characterizing the 
histology of renal masses (10).
 We have conducted this study in order to 
guide medical judgment and to more efficiently 
handle solid renal masses by attempting to determine 
if certain mass tumors can be treated non-surgically. 
This would provide for the development of a criterion 
other than the biopsy to help the therapeutic decision 
process for patients with renal masses.
MATERIALS AND METHODS
 The present study is a retrospective analysis 
of 305 consecutive patients seen at our Institution 
from 1977 to 2006, bearing incidentally or symptom-
atic solid renal masses.
 A total of 305 patients were evaluated, includ-
ing 231 males and 74 females ranging in age from 9 to 
90 years (median of 60 years). All of the patients had 
expansive kidney lesions depicted by computerized 
axial tomography or magnetic resonance imaging; 
some were solid and others had intermingled large 
solid and small cystic areas. In the patients with mul-
tiple lesions, each one was studied individually and a 
total of 328 lesions were analyzed. Taking in account 
the clinical presentation, the routine blood and urinary 
tests and the imaging studies, all lesions classified as 
inflammatory or infectious were excluded from the 
study.
 All patients were operated upon by the same 
surgeon (MS) and included radical nephrectomy (213 
pts), partial nephrectomy (24 pts), or mass enucleation 
(68 pts). The surgical specimens were analyzed by the 
same pathologist, using the UICC histopathology clas-
sification for RCC, including clear cell, chromophobe, 
papillary, Bellini duct, and sarcomatoid subtypes (11).
 Using the primary clinical outcome, an at-
tempt has been made to define the total incidence of 
benign lesions and correlate the tumor diameter with 
final histology of the lesion. The diameter was mea-
sured in the surgical specimen, taking into account the 
greatest diameter found. The histopathology findings 
were divided into benign and malignant categories, 
and the frequency of these two types was compared 
to original nodes of greater or less than 3 cm in di-
ameter.
 The differences in proportion of benign and 
malignant lesions in the groups with diameters of 
more or less than 3 cm were evaluated by statistical 
analysis with the chi-square test, adopting a signifi-
cance level of 5% (p < 0.05) for rejecting the null 
hypothesis. The strength of association between the 
two variables was analyzed by an odds ratio calcula-
tion with a confidence interval of 95% (IC at 95).
RESULTS
 In this study, the diameter of the evaluated 
lesions ranged from 0.2 cm to 24.0 cm, with a median 
of 4.0 cm. According to Table-1, among the 328 renal 
lesions found in 305 patients, 273 (83.2%) were renal 
cell carcinomas. In the other cases, 43 (13.2%) were 
benign lesions and 12 (3.6%) were non-neoplasic le-
sions.
 When the incidence of benign lesions was 
evaluated as a function of the renal mass diameter, 
a frequency of 13.3% and 22.9% was observed, 
respectively, in the masses with diameters equal or 
greater and smaller than 3 cm (Tables 2 and 3) with 
a statistically significant difference between the fre-
quency of benign pathologies and the lesion size (p 
= 0.026). These same numbers show that the chance 
of finding a malignant lesion in nodes greater than 
3 cm in diameter is 1.93 times greater (IC at 95%, 
1.07-3.46) than in nodes with diameters of 3 cm.
Table 1 –  Pathological findings in 328 renal masses.
Diagnosis N %
Renal cell carcinoma 273 83.2
Oncocytoma   23      71
Angiomyolipoma   14   4.3
Multilocular cyst     8   2.4
Cystic nephroma     3   0.9
Hematoma     2   0.6
Renal infarct     2   0.6
Hemangioma     1   0.3
Metanephric adenoma     1   0.3
Leiomyoma     1   0.3
Total 328 100.00
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COMMENTS
 This study shows that there is a true cor-
relation between the diameter or solid renal nodes 
and the incidence of benign lesions. To perform our 
analysis we compared lesion smaller or larger than 3 
cm and we choose this cut-off value because it has 
been demonstrated that it correlates well with the 
risks of metastatic disease in renal cell carcinoma. 
Metastatic disease is usually found in tumors larger 
than 3 cm (12) which makes this threshold a valuable 
clinical parameter for handling patients with solid 
renal lesions. Benign lesions were seen in 13.3% of 
210 (two hundred and ten) masses less than 3 cm in 
diameter and in 22.9% of 118 nodes greater than 3 cm 
in diameter. We believe these results are significant, as 
the present study included a large number of patients, 
the surgical specimens were all analyzed by a single 
pathologist, and the largest tumor diameter was mea-
sured in the surgical specimen. Some previous studies 
published regarding the same subject evaluated a 
smaller number of cases (13,14) and the measurement 
of the tumor size was made by imaging studies that 
show a certain variability due to heterogeneous cuts 
and random  radiologist readings (3,15,16).
 The greatest frequency of benign lesions in 
renal masses smaller than 3 cm found in our study 
agrees with other studies previously published 
(4,6,7,15). According to those studies, between 12.5% 
and 46.3% of solid renal nodes less than 3 cm in 
diameter are benign, and this frequency decreases, 
from 0% to 19.9%, when the solid mass is more than 
3 cm in diameter (7,15). A single study, published by 
Snyder et al., has shown the absence of correlation 
between the size of renal nodes and the incidence of 
benign lesions. However, this study excluded greater 
diameter masses, a fact that probably reduced the 
number of malignant lesions in this sub-group when 
the patients were treated surgically (16).
 One of the main limitations of the present study 
is that only tumor size was taken in account to predict 
the pathological outcome of the solid renal masses. It has 
been already shown that other relevant variables such 
as other radiological features, clinical presentation, age, 
gender or tumor growth velocity can help in the differen-
tial diagnosis of renal tumors (17,18). On the other hand, 
renal tumor size correlates with the risks of metastasis 
and with patient survival. Furthermore measuring tumor 
diameter is a simple way that helps physician to plan 
patient care when a more detailed analysis of imaging 
studies are not available or are incomplete.
 Fifty-five of the 328 lesions (16.8%) evalu-
ated in our study represented benign disorders, with a 
prevalence of oncocytomas (7.1%) and angiomyolipo-
mas (4.3%). This distribution is similar to that seen in 
other studies (15,16), showing that although there is 
an absence of aggressiveness, most of the benign renal 
lesions found in practice are neoplasic in nature, with 
Table 2 – Surgical specimen lesion size and pathological findings.
Lesion Size (cm) Total Number Pathology
N Malignant N Benign
≤ 3.0 118   91 (77.1%) 27 (22.9%)
>3.0 210 182 (86.7%) 28 (13.3%)
Total 328 273 (83.2%) 55 (16.8%)
Table 3 – Frequency of benign disease for every cm increase 
in tumor diameter.
Lesion Size 
(cm)
Total 
Number
Pathology
N Benign (%)
≤ 2.0   47 16 (34.0%)
2.1 - 4.0 122 16 (13.1%)
4.1 - 6.0  70 12 (17.1%)
6.1 - 8.0  36  4 (11.1%)
8.1 - 10.0  25  4 (16.0%)
≥ 10.0  28  3 (10.7%)
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a possibility of generating difficulties in interpretation 
when percutaneous biopsies are diagnosed in patients 
with solid renal lesions. In fact, in one of the contem-
porary series of percutaneous biopsies to study renal 
masses, 21% of the cases did not have the etiology 
defined on the first attempt, generating problems in 
terms of an effective therapeutic intervention (8).
 According to the data of the present study, it is 
important for specialists to consider the possibility of 
benign lesions when identifying solid or mixed renal 
nodes. The incidence of benign lesions is significantly 
greater in solid renal masses with diameters of less 
than 3 cm and this must be taken into account when 
advising patients about the relevance of the disease 
and about treatment options. In lesions with diameters 
less than 3 cm, the frequency of benign masses is al-
most twice as common as that found in greater masses. 
This finding can be relevant when we are treating 
patients with multiple bilateral small solid nodules 
or patients unsuited for surgery. In these settings, the 
use of percutaneous lesion biopsies has a great chance 
to show a benign lesion and this finding will obviate 
the need for an unnecessary surgical intervention 
(9). Furthermore, the adoption of surveillance in a 
patient with a solid renal mass can be done with less 
concern if the lesion has less than 3 cm in diameter. 
Considering that such tumors have no or negligible 
growth when followed for years (19), based on tumor 
size and tumor growth physicians can safely monitor 
their patients treated with active surveillance.
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